Yi‐Sheng Lin

Tungs' Taichung MetroHarbor Hospital

Papers

10

Total Citations

66

H-Index

5

About

Dr. Yi-Sheng Lin is a pioneering urologic surgeon whose work centers on advancing robotic-assisted surgery for prostate and kidney cancers, with a particular focus on expanding access to novel platforms and refining surgical outcomes. As the lead author of the first experience in Taiwan and Northeast Asia with the Hugo RAS system for radical prostatectomy—a study with 20 citations—Dr. Lin has established himself at the forefront of next-generation robotic technology. His major contributions include validating robotic-assisted ureteroplasty with buccal mucosa grafts (13 citations) and developing a predictive nomogram for prostate cancer detection in patients undergoing theranostic robotic-assisted laparoscopic radical prostatectomy (7 citations). With over 2,000 robotic-assisted laparoscopic radical prostatectomies performed, his comprehensive analysis of complications in this large cohort (4 citations) provides essential safety benchmarks. Dr. Lin has also demonstrated excellence in renal surgery, achieving pentafecta outcomes in robotic partial nephrectomy (5 citations), and has explored innovative applications like VR-RENDER fusion software for focal therapy. His work consistently combines technical innovation with rigorous outcomes analysis, making him a key figure in advancing minimally invasive urologic oncology.

Research Focus

Key Achievements

5
H-Index
10
Papers
66
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Robot‐assisted radical prostatectomy using hugo RAS system: The pioneer experience in Taiwan and Northeast Asia
20 citations · 2023
📈 Most Prolific Year: 2023 (3 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Tungs' Taichung MetroHarbor Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago